by charles.henry.dion@iktos.com | Apr 29, 2024 | Blog
A new generation of startups AI-boosted is designing exclusive molecules that could become tomorrow’s cancer treatments. This thematic was central during the last forum Impact santé organized by La Tribune on Thursday. Follow this link to learn more on how Iktos is...
by charles.henry.dion@iktos.com | Apr 4, 2024 | Blog
Nicolas Do Huu, CTO and Co-founder of Iktos was interviewed by François Sorel in Tech & Co from BFM Business. He discussed the acceleration of the drug discovery process thanks to the Iktos robotic platform during the AWS summit. Watch the full interview...
by charles.henry.dion@iktos.com | Mar 20, 2024 | Blog
Iktos has been featured in an article titled « Iktos, the French machine that will discover the drugs of tomorrow » by French magazine Le Point. This article comes back on the major partnership recently announced between Iktos and Elsevier to deliver a predictive...
by charles.henry.dion@iktos.com | Mar 5, 2024 | PR
Iktos and Elsevier partner to deliver a predictive retrosynthesis and synthetic accessibility platform. Combining the world’s largest chemistry database, Reaxys from Elsevier, with cutting-edge AI from Iktos, the advanced platform will enable pharmaceutical companies...
by charles.henry.dion@iktos.com | Feb 23, 2024 | Job vacancies
Apply Here Job details Title: Synthetic Chemist for the Robotic Platform Location: Iktos Robotics Lab at Villebon / Yvette Period: 4-6 months (Spring/Summer 2024) Start: April-May 2024 (Spring 2024) Compensation: to be defined Weekly hours: Full-time, on-site, from...